This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
emr:ap_by_disease [2024/09/12 18:19] – created admin | emr:ap_by_disease [2024/09/12 18:24] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | # COPD | + | ================================= |
+ | # Allergic rhinitis | ||
+ | ================================== | ||
+ | @@@ | ||
- | # ASTHMA | + | - intranasal :: fluticasone daily |
+ | - anti-histamine :: loratidine 10 mg daily | ||
+ | - LTRA :: montelukast 10 mg daily | ||
+ | ================ | ||
+ | # Asthma, @@@ | ||
+ | ================ | ||
+ | @@@ | ||
+ | |||
+ | - PFTs :: @@@ | ||
+ | |||
+ | - inhaler, controller :: @@@ | ||
+ | - inhaler, reliever :: albuterol MDI | ||
+ | - steroids :: @@@ | ||
+ | - biologics :: @@@ | ||
+ | |||
+ | |||
+ | ================ | ||
+ | # Asthma, @@@ | ||
+ | ================ | ||
+ | @@@ | ||
+ | |||
+ | - PFTs :: @@@ | ||
+ | |||
+ | - inhaler, controller :: @@@ | ||
+ | - inhaler, reliever :: albuterol MDI | ||
+ | - steroids :: @@@ | ||
+ | - biologics :: @@@ | ||
+ | |||
+ | ================ | ||
+ | # COPD, GOLD @@@ | ||
+ | ================ | ||
+ | @@@ | ||
+ | |||
+ | - PFTs :: @@@ | ||
+ | |||
+ | - inhaler, controller :: @@@ | ||
+ | - inhaler, reliever :: albuterol MDI | ||
+ | - steroids :: @@@ | ||
+ | - PDE4 :: not indicated | ||
+ | |||
+ | ================================= | ||
+ | # Gastroesophageal Reflux Disease | ||
+ | ================================= | ||
+ | @@@ | ||
+ | |||
+ | - H2R :: @@@ | ||
+ | - PPI :: @@@ | ||
+ | - H pylori status :: @@@ | ||
+ | |||
+ | |||
+ | ================================ | ||
+ | # Immunodeficiency due to medications | ||
+ | # Long term (current) use of immunosuppression | ||
+ | # Drug Therapy Requiring Intensive Monitoring for Toxicity | ||
+ | ================================ | ||
+ | @@@ | ||
+ | |||
+ | Diagnostics | ||
+ | - labs :: @@@ | ||
+ | - imaging :: @@@ | ||
+ | - PFTs :: @@ | ||
+ | - EKG @@@ | ||
+ | Interventions | ||
+ | - steroids :: @@@ | ||
+ | - non-steroidals :: @@@ | ||
+ | |||
+ | |||
+ | ================================ | ||
+ | # Pulmonary Sarcoidosis, | ||
+ | ================================ | ||
+ | @@@ | ||
+ | |||
+ | Diagnostics | ||
+ | - annual eye exams | ||
+ | - DEXA :: @@@ | ||
+ | - labs :: vitamin D 1,25; LFTs; BMP | ||
+ | - imaging :: @@@ | ||
+ | - PFTs :: @@ | ||
+ | - EKG @@@ | ||
+ | Interventions | ||
+ | - steroids :: @@@ | ||
+ | - non-steroidals :: @@@ | ||
+ | |||
+ | =========================== | ||
+ | # Tobacco use disorder, @@@ | ||
+ | # History of @@@ pack years | ||
+ | =========================== | ||
+ | @@@ | ||
+ | |||
+ | - lung cancer screening :: see below | ||
+ | - vaccines :: see below | ||
+ | - nictoine replacement :: @@@ | ||
+ | |||
+ | |||
+ | ================================ | ||
+ | # Immunodeficiency due to medications | ||
+ | # Long term (current) use of immunosuppression | ||
+ | # Drug Therapy Requiring Intensive Monitoring for Toxicity | ||
+ | ================================ | ||
+ | @@@ | ||
+ | |||
+ | Diagnostics | ||
+ | - labs :: @@@ | ||
+ | - imaging :: @@@ | ||
+ | - PFTs :: @@ | ||
+ | - EKG @@@ | ||
+ | Interventions | ||
+ | - steroids :: @@@ | ||
+ | - non-steroidals :: @@@ | ||
+ | |||
+ | =========================== | ||
+ | # Pulmonary Healthcare Maintenance | ||
+ | =========================== | ||
+ | @@@ | ||
+ | |||
+ | Tobacco related | ||
+ | - lung cancer screening :: | ||
+ | - AAA screen :: | ||
+ | Immunizations | ||
+ | - pneumococcal :: | ||
+ | - influenza :: | ||
+ | - SARS-COV-2 :: |